Is metformin use associated with low mortality in patients with type 2 diabetes mellitus hospitalized for COVID-19? a multivariable and propensity score-adjusted meta-analysis.

Published in: PloS one (2023)

Our results suggest that there is a significant association between the reduction of in-hospital mortality and outpatient metformin therapy for type 2 diabetes mellitus in patients hospitalized for COVID-19.

Keyphrases

coronavirus disease
sars cov
systematic review
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
cardiovascular events
meta analyses
patient reported outcomes
coronary artery disease
respiratory syndrome coronavirus
patient reported